Read the article<\/a><\/p>\n![\"\"](\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg\")
<\/p>","protected":false},"excerpt":{"rendered":"
By recently ruling that a drug prescription assistance software qualified as a medical device, the CJEU has indirectly sent a reminder to IT companies seeing new opportunities in health care that their technology may fall under EU regulation. Frank Valentin and Charlotte H\u00e9bert-Salomon\u00a0analyse the December 7, 2017 ruling and its consequences for the certification of […]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5964","post","type-post","status-publish","format-standard","hentry","category-medias","expertise-droit-de-la-propriete-intellectuelle","expertise-droit-des-technologies-de-linformation-et-de-protection-des-donnees"],"yoast_head":"\n
Further Guidance from the CJEU on E-health - Advant Altana<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:fr]Further Guidance from the CJEU on E-health[:en]Further Guidance from the CJEU on E-health[:] - Advant Altana\" \/>\n<meta property=\"og:description\" content=\"By recently ruling that a drug prescription assistance software qualified as a medical device, the CJEU has indirectly sent a reminder to IT companies seeing new opportunities in health care that their technology may fall under EU regulation. Frank Valentin and Charlotte H\u00e9bert-Salomon\u00a0analyse the December 7, 2017 ruling and its consequences for the certification of […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health\" \/>\n<meta property=\"og:site_name\" content=\"Advant Altana\" \/>\n<meta property=\"article:published_time\" content=\"2018-04-13T14:05:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-11-23T09:23:35+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg\" \/>\n<meta name=\"author\" content=\"Altana Communication\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Altana Communication\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health\",\"url\":\"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health\",\"name\":\"[:fr]Further Guidance from the CJEU on E-health[:en]Further Guidance from the CJEU on E-health[:] - Advant Altana\",\"isPartOf\":{\"@id\":\"https:\/\/backup.altanalaw.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health#primaryimage\"},\"image\":{\"@id\":\"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health#primaryimage\"},\"thumbnailUrl\":\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg\",\"datePublished\":\"2018-04-13T14:05:53+00:00\",\"dateModified\":\"2018-11-23T09:23:35+00:00\",\"author\":{\"@id\":\"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health#primaryimage\",\"url\":\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg\",\"contentUrl\":\"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/backup.altanalaw.com\/#website\",\"url\":\"https:\/\/backup.altanalaw.com\/\",\"name\":\"Advant Altana\",\"description\":\"Soci\u00e9t\u00e9 d'avocats \u00e0 la Cour de Paris\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/backup.altanalaw.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6\",\"name\":\"Altana Communication\",\"url\":\"https:\/\/backup.altanalaw.com\/en\/author\/altanacomm\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:fr]Further Guidance from the CJEU on E-health[:en]Further Guidance from the CJEU on E-health[:] - Advant Altana","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"[:fr]Further Guidance from the CJEU on E-health[:en]Further Guidance from the CJEU on E-health[:] - Advant Altana","og_description":"By recently ruling that a drug prescription assistance software qualified as a medical device, the CJEU has indirectly sent a reminder to IT companies seeing new opportunities in health care that their technology may fall under EU regulation. Frank Valentin and Charlotte H\u00e9bert-Salomon\u00a0analyse the December 7, 2017 ruling and its consequences for the certification of […]","og_url":"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health","og_site_name":"Advant Altana","article_published_time":"2018-04-13T14:05:53+00:00","article_modified_time":"2018-11-23T09:23:35+00:00","og_image":[{"url":"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg"}],"author":"Altana Communication","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Altana Communication","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health","url":"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health","name":"[:fr]Further Guidance from the CJEU on E-health[:en]Further Guidance from the CJEU on E-health[:] - Advant Altana","isPartOf":{"@id":"https:\/\/backup.altanalaw.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health#primaryimage"},"image":{"@id":"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health#primaryimage"},"thumbnailUrl":"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg","datePublished":"2018-04-13T14:05:53+00:00","dateModified":"2018-11-23T09:23:35+00:00","author":{"@id":"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/backup.altanalaw.com\/en\/medias\/further-guidance-from-the-cjeu-on-e-health#primaryimage","url":"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg","contentUrl":"http:\/\/backup.altanalaw.com\/wp-content\/uploads\/2018\/04\/FV-CHS-300x148.jpg"},{"@type":"WebSite","@id":"https:\/\/backup.altanalaw.com\/#website","url":"https:\/\/backup.altanalaw.com\/","name":"Advant Altana","description":"Soci\u00e9t\u00e9 d'avocats \u00e0 la Cour de Paris","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/backup.altanalaw.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6","name":"Altana Communication","url":"https:\/\/backup.altanalaw.com\/en\/author\/altanacomm"}]}},"_links":{"self":[{"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/posts\/5964"}],"collection":[{"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/comments?post=5964"}],"version-history":[{"count":5,"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/posts\/5964\/revisions"}],"predecessor-version":[{"id":6008,"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/posts\/5964\/revisions\/6008"}],"wp:attachment":[{"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/media?parent=5964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/categories?post=5964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/backup.altanalaw.com\/en\/wp-json\/wp\/v2\/tags?post=5964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}